Michelle Escano

Publications

Citations

H-Index

2022

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of North Carolina at Chapel Hill

Michelle Escano is an author at The University of Texas MD Anderson Cancer Center specializing in radiation oncology, colorectal cancer, and tumor immunity.

Top concepts

MedicineOncologyPathologyImmunologyImmunotherapyCancer TherapyTumor ImmunityColorectal CancerMolecular OncologyRadiation Oncology

Publications per year

2022–2022

Publications

Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, BRAFV600E metastatic colorectal cancer.

Van K. Morris, Christine M. Parseghian, Michelle Escano et al. · Journal of Clinical Oncology · 2022 · 76 citations

Braf V600e Crc, Immunology, Pathology +16

Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable (MSS), BRAFV600E metastatic colorectal cancer.

Van K. Morris, Christine M. Parseghian, Michelle Escano et al. · Journal of Clinical Oncology · 2022 · 16 citations

Prior Braf, Braf V600e Crc, Immunology +16

Rows per page

1–2 of 2